Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain [Phase 3]
Update on a Phase 3 trial evaluating reduced-dose versus standard-dose radiotherapy for nasopharyngeal carcinoma. The study is sponsored by …
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Metastatic Nasopharyngeal Carcinoma [Phase 1]
A Phase 1 clinical trial for metastatic nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial is evaluating toripalimab plus GP induction chemotherapy versus placebo with GP in locoregionally advanced nasopharyngeal ca…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: An MRI Study
This clinical trial update describes a study investigating how APOE gene polymorphism regulates blood-brain barrier permeability and its imp…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial examines CTV delineation based solely on geometric expansion from GTV in nasopharyngeal carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas [NA]
A recruiting clinical trial comparing plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA to screen for nasopharyngeal carcinoma in high-risk areas…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating whether sodium bicarbonate can reduce radiation-induced oral mucositis in patients with nasopharyng…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. [Phase 2]
A Phase 2 clinical trial is evaluating GAPP induction and concurrent chemoradiotherapy followed by toripalimab maintenance for nasopharyngea…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: CD70-targeted immunoPET Imaging of Malignant Cancers [NA]
A clinical trial evaluating CD70-targeted immunoPET imaging in multiple cancers is currently recruiting, including renal cell carcinoma, dif…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
This clinical trial entry describes the development and validation of a deep learning model to predict distant metastases in nasopharyngeal …
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients [NA]
This clinical trial update reports a study evaluating pretreatment with hydroxychloroquine before radiotherapy and chemotherapy in patients …
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
A Phase III study of YL201 for recurrent or metastatic Nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating reduced-volume neck prophylactic irradiation in nasopharyngeal carcinoma. The study is currently recruitin…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma [NA]
A clinical trial is recruiting to evaluate hypofractionated radiotherapy for nasopharyngeal carcinoma at The Second Affiliated Hospital of H…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
A recruiting clinical trial exploring whether circulating tumor cells can detect chemosensitivity and predict treatment efficacy in metastat…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
A Sun Yat-sen University trial is evaluating whether a multi-omics approach can predict the efficacy of chemoradiotherapy with immunotherapy…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: "Xijiang Project" Screening Cohort for NPC
Update on the Xijiang Project screening cohort for nasopharyngeal carcinoma; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase II study evaluating TPF chemotherapy with a PD-1 inhibitor as induction therapy for locally advanced nasopharyngeal carcinoma; not yet…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Adebrelimab and Chemoradiotherapy in High-risk LANPC [Phase 2]
A Phase 2 clinical trial evaluating Adebrelimab in combination with chemoradiotherapy for high-risk locally advanced nasopharyngeal carcinom…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer [Phase 3]
This Phase 3 trial investigates whether reducing the radiation dose and irradiated volume during cervical prophylactic irradiation is effect…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: Monitoring Salivary Gland Injury in Nasopharyngeal Carcinoma Patients After Radiotherapy Using Multi-Modal Radiomics
This clinical trial protocol from Hainan Medical College aims to monitor salivary gland injury in nasopharyngeal carcinoma patients after ra…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC [Phase 2]
Phase 2 trial evaluating mitoxantrone hydrochloride liposome combined with a PD-1 inhibitor for recurrent or metastatic nasopharyngeal carci…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
This document updates a Phase 3 trial comparing GP (gemcitabine plus cisplatin) versus PF (cisplatin plus fluorouracil) as induction chemoth…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma
This clinical trial update notes the status of a study on tertiary lymphoid structures in nasopharyngeal carcinoma, sponsored by Jiangxi Pro…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC [Phase 2]
Phase 2 trial evaluating irinotecan liposome in combination with S-1 for PD-1/PD-L1 inhibitor-refractory recurrent or metastatic nasopharyng…